Legal & General Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Buy |
713,576
+37,699
| +6% | +$686K | ﹤0.01% | 1056 |
|
|
2025
Q1 | $13.4M | Sell |
675,877
-160,973
| -19% | -$3.19M | ﹤0.01% | 980 |
|
|
2024
Q4 | $14.4M | Buy |
836,850
+164,013
| +24% | +$2.81M | ﹤0.01% | 973 |
|
|
2024
Q3 | $13.5M | Buy |
672,837
+438,527
| +187% | +$8.77M | ﹤0.01% | 1017 |
|
|
2024
Q2 | $2.62M | Buy |
234,310
+10,904
| +5% | +$122K | ﹤0.01% | 1824 |
|
|
2024
Q1 | $1.47M | Buy |
223,406
+42,025
| +23% | +$277K | ﹤0.01% | 2049 |
|
|
2023
Q4 | $820K | Buy |
181,381
+4,876
| +3% | +$22K | ﹤0.01% | 2269 |
|
|
2023
Q3 | $632K | Buy |
176,505
+14,862
| +9% | +$53.2K | ﹤0.01% | 2343 |
|
|
2023
Q2 | $596K | Buy |
161,643
+84,565
| +110% | +$312K | ﹤0.01% | 2402 |
|
|
2023
Q1 | $255K | Buy |
77,078
+7,883
| +11% | +$26.1K | ﹤0.01% | 2497 |
|
|
2022
Q4 | $268K | Buy |
69,195
+49,722
| +255% | +$193K | ﹤0.01% | 2500 |
|
|
2022
Q3 | $47K | Sell |
19,473
-7,317
| -27% | -$17.7K | ﹤0.01% | 2984 |
|
|
2022
Q2 | $53K | Buy |
+26,790
| New | +$53K | ﹤0.01% | 2995 |
|
|
2021
Q2 | – | Sell |
-7,063
| Closed | -$12K | – | 3479 |
|
|
2021
Q1 | $12K | Hold |
7,063
| – | – | ﹤0.01% | 3319 |
|
|
2020
Q4 | $14K | Hold |
7,063
| – | – | ﹤0.01% | 3212 |
|
|
2020
Q3 | $17K | Sell |
7,063
-3,397
| -32% | -$8.18K | ﹤0.01% | 3016 |
|
|
2020
Q2 | $31K | Hold |
10,460
| – | – | ﹤0.01% | 2876 |
|
|
2020
Q1 | $30K | Buy |
10,460
+335
| +3% | +$961 | ﹤0.01% | 2757 |
|
|
2019
Q4 | $41K | Buy |
10,125
+1,748
| +21% | +$7.08K | ﹤0.01% | 2887 |
|
|
2019
Q3 | $37K | Buy |
8,377
+3,362
| +67% | +$14.8K | ﹤0.01% | 2863 |
|
|
2019
Q2 | $19K | Buy |
5,015
+2,204
| +78% | +$8.35K | ﹤0.01% | 3206 |
|
|
2019
Q1 | $11K | Hold |
2,811
| – | – | ﹤0.01% | 3234 |
|
|
2018
Q4 | $7K | Hold |
2,811
| – | – | ﹤0.01% | 3301 |
|
|
2018
Q3 | $17K | Hold |
2,811
| – | – | ﹤0.01% | 3244 |
|
|
2018
Q2 | $13K | Buy |
+2,811
| New | +$13K | ﹤0.01% | 3271 |
|